What is Invivox?
Invivox is a prominent online training platform dedicated to providing practical, interdisciplinary, and accessible educational content for healthcare professionals. Boasting over 2,500 courses and more than 500,000 registrations, the platform serves as a vital resource for enhancing everyday medical practice. Content is curated by leading experts and renowned institutions, ensuring a high standard of medical education. Invivox primarily targets healthcare providers seeking to elevate their skills and knowledge across a broad spectrum of medical specialties, positioning itself as a key player in the professional development of the healthcare workforce.
How much funding has Invivox raised?
Invivox has raised a total of $2.3M across 2 funding rounds:
Angel/Seed
$967K
Unspecified
$1.3M
Angel/Seed (2016): $967K with participation from ISAI and Web Technology Inc.
Unspecified (2016): $1.3M led by Isai
Key Investors in Invivox
Isai
ISAI is a venture capital fund that focuses on early-stage and growth-stage technology entrepreneurs, offering services in early stage VC, corporate VC, growth buyout, and growth lending. They are committed to ESG principles in their investment philosophy.
ISAI and Web Technology Inc.
ISAI specializes in bespoke software development and systems integration for the Electronic Manufacturing Services industry, aiming to enhance operational efficiency and productivity. They create tailored solutions and are dedicated to transforming and optimizing manufacturing operations.
What's next for Invivox?
The substantial enterprise-level funding indicates Invivox is poised for significant scaling and strategic growth. This capital injection will likely fuel platform enhancements, expansion into new medical domains, and potentially broader market penetration. The company's focus on high-quality, expert-led content suggests a strategy centered on becoming the go-to resource for continuous professional development in healthcare, aiming to solidify its market leadership and impact on medical practice globally.
See full Invivox company page